Evidence map›Paper›PMID 31758543›Full record

ArticleBiotechnology and bioengineering2020

A multiplexed in vitro assay system for evaluating human skeletal muscle functionality in response to drug treatment.

Sarah A Najjar, Alexander S T Smith, Christopher J Long, Christopher W McAleer, Yunqing Cai, Balaji Srinivasan, Candace Martin, Herman H Vandenburgh, James J Hickman

Open access · greenAbstract read
In one paragraph

Article in Biotechnology and bioengineering, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sarah A NajjarNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0003-1959-8658
Alexander S T SmithNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0002-0001-8484
Christopher J LongNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0002-2333-7576
Christopher W McAleerNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0002-9550-7458
Yunqing CaiNanoScience Technology Center, University of Central Florida, Orlando, Florida.
Balaji SrinivasanNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0002-1430-7818
Candace MartinNanoScience Technology Center, University of Central Florida, Orlando, Florida.
Herman H VandenburghDepartment of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island.
James J HickmanNanoScience Technology Center, University of Central Florida, Orlando, Florida.ORCID 0000-0002-1621-3006
University of Central Florida · USBrown University · US

Funding

An In Vitro Model of Stem Cell Innervation of MyotubesR01NS050452 · NINDS · UNIVERSITY OF CENTRAL FLORIDA · PI HICKMAN, JAMES J · 2005 to 2020
$6.4M
NINDS NIH HHS R01 NS050452
6 · The paper itself

Abstract

In vitro systems that mimic organ functionality have become increasingly important tools in drug development studies. Systems that measure the functional properties of skeletal muscle are beneficial to compound screening studies and also for integration into multiorgan devices. To date, no studies have investigated human skeletal muscle responses to drug treatments at the single myotube level in vitro. This report details a microscale cantilever chip-based assay system for culturing individual human myotubes. The cantilevers, along with a laser and photo-detector system, enable measurement of myotube contractions in response to broad-field electrical stimulation. This system was used to obtain baseline functional parameters for untreated human myotubes, including peak contractile force and time-to-fatigue data. The cultured myotubes were then treated with known myotoxic compounds and the resulting functional changes were compared to baseline measurements as well as known physiological responses in vivo. The collected data demonstrate the system's capacity for screening direct effects of compound action on individual human skeletal myotubes in a reliable, reproducible, and noninvasive manner. Furthermore, it has the potential to be utilized for high-content screening, disease modeling, and exercise studies of human skeletal muscle performance utilizing iPSCs derived from specific patient populations such as the muscular dystrophies.

Indexed as

Models, BiologicalMuscle, SkeletalAtorvastatinCells, CulturedDoxorubicinDrug Evaluation, PreclinicalHumansInduced Pluripotent Stem CellsLab-On-A-Chip DevicesMuscle ContractionMuscle Fibers, SkeletalMuscular DystrophiesAtorvastatinDoxorubicinbody-on-a-chipcantileversfunctional assayhumanskeletal muscle

Identifiers

PMID31758543
PMCPMC9336783
OpenAlexW2990143923

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.